Clinical Trial Update: GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma [NA]

View source ↗

Summary

A clinical trial is recruiting to assess GEMOX combined with targeted therapy and immunotherapy for advanced cholangiocarcinoma, sponsored by Tianjin Medical Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Cholangiocarcinoma | NA | Status: RECRUITING